FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Signup
  1. Home
  2. NATHBIOGEN Forum

NATHBIOGEN

326.85 +0.7 (0.21%)
Updated 03:29 24/09 IST
0% Bullish
0% Bearish
0 Users have submitted 0 trade ideas of Rs. 0 for NATHBIOGEN
Disclaimer

Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See NATHBIOGEN Share Price Targets >>

NATHBIOGEN Share Price Discussion

S
Shubham Pote @shubhampote
Reputation: 0 • Aug 6 3:11 AM
Type
Buy
Instrument
NATHBIOGEN
Entry Price
₹401
Price@Trade
₹389.2
Target Price
₹600
Stop Price
₹300
Valid Till
Aug 5, 2022 3:20 AM
Margin
₹4,010 approx for 10 Qty
Status
Waiting for entry

#NATHBIOGEN
Like
Reply
swap_vert
Trade
O
Omkar Patade @omkarpatade
Reputation: 0 • Aug 4 3:36 AM
Type
Buy
Instrument
NATHBIOGEN
Entry Price
₹385
Price@Trade
₹385
Target Price
₹407
Stop Price
₹362
Valid Till
Aug 4, 2022 3:20 AM
Margin
₹38,500 approx for 100 Qty
Status
Active
#NATHBIOGEN
Like
Reply
swap_vert
Trade
C
Chartsandequity @chartsandequity
Reputation: 2,347 • Jun 22 8:36 AM
Buy Nath Bio at 416.
Dips till 401 is a buying opportunity
Target 495 - 542

#NATHBIOGEN
Like
Reply
S
Siddharth @siddharth-HyL4SABiu
Reputation: 0 • Jun 17 7:55 AM
Type
Buy
Instrument
NATHBIOGEN
Entry Price
₹416.9  ₹417.1
Price@Trade
₹416.5
Target Price
₹500
Stop Price
₹400
Valid Till
Jun 17, 2022 3:20 AM
Margin
₹41,710 approx for 100 Qty
Status
Exited
Exit Price
₹420.1
Net P&L
+₹300 (+0.72%)
#NATHBIOGEN
Like
Reply (3)
swap_vert
Trade
See all replies
Siddharth @siddharth-HyL4SABiu
•
Jun 17 7:56 AM
Update
Entry Price Modified
Price @ Update
₹417.1
Original Entry Price
₹416.9
New Entry Price
416.5
TrackerBot @trackerbot
•
Jun 17 7:57 AM
Update
Trade Entered
Entry Price
₹417.1
Siddharth @siddharth-HyL4SABiu
•
Jun 21 7:30 AM
Update
Exited
Exit Price
₹420.1
Net P&L
+₹300 (+0.72%)
S
Suryansh @suryansh-H1KO7t-P_
Reputation: 16 • Jun 15 7:54 AM
Like
Reply
S
Suryansh @suryansh-H1KO7t-P_
Reputation: 16 • Jun 15 3:48 AM
Like
Reply
R
Rajesh @razipix
Reputation: 440 • May 16 2:59 AM
Like
Reply
A
Abdul Latif @abdullatif
Reputation: 0 • May 14 3:59 AM
Type
Buy
Instrument
NATHBIOGEN
Entry Price
₹461.95
Price@Trade
₹461.95
Target Price
₹480
Stop Price
₹455
Valid Till
May 14, 2021 3:20 AM
Margin
₹8,777.05 approx for 19 Qty
Status
Stoploss Hit
Exit Price
₹455
Net P&L
-₹132.05 (-1.5%)
#NATHBIOGEN
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
•
May 14 4:02 AM
Update
Stoploss Hit
Exit Price
₹455
B
Bharath @bharath-rkhrOyIy_
Reputation: 0 • May 14 3:58 AM
Type
Buy
Instrument
NATHBIOGEN
Entry Price
₹462.65
Price@Trade
₹464.7
Target Price
₹472.7
Stop Price
₹452.7
Valid Till
May 14, 2021 3:20 AM
Margin
₹46,265 approx for 100 Qty
Status
Exited
Exit Price
₹452.2
Net P&L
-₹1,045 (-2.26%)
#NATHBIOGEN
Like
Reply (2)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
•
May 14 3:59 AM
Update
Trade Entered
Entry Price
₹462.65
Bharath @bharath-rkhrOyIy_
•
May 14 4:01 AM
Update
Exited
Exit Price
₹452.2
Net P&L
-₹1,045 (-2.26%)
N
naveen george @naveengeorge-BkW...
Reputation: 0 • Apr 30 6:16 AM
Type
Buy
Instrument
NATHBIOGEN
Entry Price
₹360
Price@Trade
₹360
Target Price
₹364
Stop Price
₹356
Valid Till
Apr 30, 2021 3:20 AM
Margin
₹163,800 approx for 455 Qty
Status
Stoploss Hit
Exit Price
₹356
Net P&L
-₹1,820 (-1.11%)
#NATHBIOGEN
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
•
Apr 30 7:06 AM
Update
Stoploss Hit
Exit Price
₹356
S
SWING TRADERS @swingtraders
Reputation: 0 • Jan 21 3:32 AM
Type
Buy
Instrument
NATHBIOGEN
Entry Price
₹299.05
Price@Trade
₹299.05
Target Price
₹3,000
Stop Price
₹230
Valid Till
Feb 19, 2021 3:20 AM  May 24, 2021 3:20 AM
Margin
₹59,810 approx for 200 Qty
Status
Validity Over
Exit Price
₹424
Net P&L
+₹24,990 (+41.78%)
#NATHBIOGEN
Like
Reply (3)
swap_vert
Trade
See all replies
SWING TRADERS @swingtraders
•
Feb 16 3:52 AM
Update
Time Extended
Price @ Update
₹268.7
Original Time
Feb 19, 2021 3:20 AM
New Time
Apr 7, 2021 3:20 AM
SWING TRADERS @swingtraders
•
Mar 5 7:20 AM
Update
Time Extended
Price @ Update
₹306
Original Time
Apr 7, 2021 3:20 AM
New Time
May 24, 2021 3:20 AM
TrackerBot @trackerbot
•
May 24 8:51 AM
Update
Validity Over
Exit Price
₹424
Net P&L
+₹24,990 (+41.78%)
N
NewsBot @newsbot
Reputation: 15,827 • Aug 10, 2020 3:58 AM
Nath Bio-Genes Standalone June 2020 Net Sales at Rs 193.25 crore, up 16.45% Y-o-Y
Moneycontrol
Like
Reply
N
NewsBot @newsbot
Reputation: 15,827 • Aug 10, 2020 3:58 AM
Nath Bio-Genes Standalone June 2020 Net Sales at Rs 193.25 crore, up 16.45% Y-o-Y
Moneycontrol
Like
Reply
V
Vipul @vipul-rJhmwRM1v
Reputation: 0 • Aug 7, 2020 3:15 AM
Type
Buy
Instrument
NATHBIOGEN
Entry Price
₹403.55
Price@Trade
₹403.55
Target Price
₹440
Stop Price
₹370
Valid Till
Aug 14, 2020 3:20 AM
Margin
₹40,355 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹370
Net P&L
-₹3,355 (-8.31%)
#NATHBIOGEN
Like
Reply (1)
swap_vert
Trade
See all replies
TrackerBot @trackerbot
•
Aug 10, 2020 2:55 AM
Update
Stoploss Hit
Exit Price
₹370
N
NewsBot @newsbot
Reputation: 15,827 • Jun 16, 2020 2:58 AM
Nath Bio-Genes Standalone March 2020 Net Sales at Rs 60.64 crore, up 14.99% Y-o-Y
Moneycontrol
Like
Reply
C
ChartArt @ChartArt
Reputation: 388 • Jun 2, 2020 2:45 AM
NATHBIOGEN - chart - 850113
#ChartArt #EducationalPurposes #NATHBIOGEN
#Bullish #CupandHandle | CMP 334
Like
Reply
N
NewsBot @newsbot
Reputation: 15,827 • Jan 31, 2020 6:43 AM
Nath Bio-Genes Standalone December 2019 Net Sales at Rs 33.44 crore, up 18.31% Y-o-Y
Moneycontrol
Like
Reply
N
NewsBot @newsbot
Reputation: 15,827 • Aug 5, 2019 11:48 AM
Nath Bio-Genes Standalone June 2019 Net Sales at Rs 165.95 crore, up 30.04% Y-o-Y
moneycontrol.com
Like
Reply
N
NewsBot @newsbot
Reputation: 15,827 • May 30, 2019 11:18 AM
Like
Reply

NATHBIOGEN Ratings

Long term NATHBIOGEN rating by FrontPage users
  • ★
    ★
  • ★
    ★
  • ★
    ★
  • ★
    ★
  • ★
    ★
0/5 (0 Ratings)0
Find answers to all your questions on live NATHBIOGEN message board: Is NATHBIOGEN buy or sell? Should I buy NATHBIOGEN shares? Why are NATHBIOGEN shares falling? Should I invest in NATHBIOGEN stock?

Join FrontPage
Hero Img
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Join FrontPage

  • NATHBIOGEN - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization782.23
    Enterprise Value769.57
    Price to Earnings26.97
    Price to Book Value1.67
    Return on Capital Employed0.08
    Return on Equity0.06
    Face Value10
    Dividend YieldNA

  • NATHBIOGEN Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 24328.75336.95325326.05
    Sep 23331.05334.05324.6326.15
    Sep 22328334327.05328.45
    Sep 21325.2330322.4325.9
    Sep 20329.5338325.05327.6

  • NATHBIOGEN Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹333.55
    30 Day Moving Average₹334.1
    50 Day Moving Average₹348.84
    100 Day Moving Average₹375.68
    200 Day Moving Average₹336.44

  • NATHBIOGEN - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue191169.730.13
    Operating Profit4028.850.39
    Profit Before Tax3016.750.79
    Net Income2916.280.78

  • NATHBIOGEN - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds469137.582.41
    Total Liabilities101151.78-0.33
    Total Assets571289.360.97

  • NATHBIOGEN - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity-463.34-14.77
    Cash from Investing Activity-4-4.05-0.01
    Cash from Financing Activity895.3315.7
    Net Cash Flow384.627.23

  • NATHBIOGEN - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.050.06
    Return on Equity0.060.12
    Return on Capital Employed0.080.13

  • NATHBIOGEN - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.03
    3 Year CAGR Growth in Operating Profit0.15
    3 Year CAGR Growth in EBIDTA0.1
    3 Year CAGR Growth in Net Income0.14
    3 Yr CAGR Growth - Diluted EPS-0.04

  • NATHBIOGEN - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.39
    5 Year CAGR Growth in Operating Profit1.01
    5 Year CAGR Growth in EBIDTA0.91
    5 Year CAGR Growth in Net Income1.47
    3 Yr CAGR Growth - Diluted EPS1.08

  • NATHBIOGEN - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 10, 2020 3:58 AM
    Nath Bio-Genes Standalone June 2020 Net Sales at Rs 193.25 crore, up 16.45% Y-o-Y
    Moneycontrol
    NewsBot
    Aug 10, 2020 3:58 AM
    Nath Bio-Genes Standalone June 2020 Net Sales at Rs 193.25 crore, up 16.45% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 16, 2020 2:58 AM
    Nath Bio-Genes Standalone March 2020 Net Sales at Rs 60.64 crore, up 14.99% Y-o-Y
    Moneycontrol
    NewsBot
    Jan 31, 2020 6:43 AM
    Nath Bio-Genes Standalone December 2019 Net Sales at Rs 33.44 crore, up 18.31% Y-o-Y
    Moneycontrol
    NewsBot
    Aug 5, 2019 11:48 AM
    Nath Bio-Genes Standalone June 2019 Net Sales at Rs 165.95 crore, up 30.04% Y-o-Y
    moneycontrol.com
    NewsBot
    May 30, 2019 11:18 AM
    NewsBot
    Feb 4, 2019 6:37 AM
    NewsBot
    Oct 31, 2018 11:22 AM

  • NATHBIOGEN - Related Communities

    keyboard_arrow_down
    Avanti Feeds Ltd. NSE: AVANTIFEED | B...
    LT Foods Ltd. NSE: DAAWAT | BSE: 5327...
    Venky's (India) Ltd. NSE: VENKEYS | B...
    Jain Irrigation Systems Ltd. NSE: JIS...
    KRBL Ltd. NSE: KRBL | BSE: 530813 | I...
    Advanced Enzyme Technologies Ltd. NSE...
    Waterbase Ltd. NSE: WATERBASE | BSE: ...
    Kohinoor Foods Ltd. NSE: KOHINOOR | B...
    Agri-Tech (India) Ltd. NSE: AGRITECH ...
    Proseed India Ltd. NSE: PROSEED | BSE...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.